Literature DB >> 26902223

Cross-Neutralization Activity of Single-Chain Variable Fragment (scFv) Derived from Anti-V3 Monoclonal Antibodies Mediated by Post-Attachment Binding.

Yasuhiro Maruta1, Takeo Kuwata, Kazuki Tanaka, Muntasir Alam, Kristel Paola Ramirez Valdez, Yoshika Egami, Yoshiaki Suwa, Hiroshi Morioka, Shuzo Matsushita.   

Abstract

The V3 loop in the envelope (Env) of HIV-1 is one of the major targets of neutralizing antibodies. However, this antigen is hidden inside the Env trimer in most isolates and is fully exposed only during CD4-gp120 interaction. Thus, primary HIV-1 isolates are relatively resistant to anti-V3 antibodies because IgG is too large to access the V3 loop. To overcome this obstacle, we constructed single-chain variable fragments (scFvs) from anti-V3 monoclonal antibodies 0.5γ, 5G2, and 16G6. Enhanced neutralization by 0.5γ and 5G2 scFvs was observed in strains resistant to their IgG counterparts. Neutralization coverage by 0.5γ scFv reached up to 90% of the tested viruses (tier 2 and 3 classes). The temperature-regulated neutralization assay revealed that extensive cross-neutralization of 0.5γ scFv can be explained by post-attachment neutralization. Neutralization assay involving viruses carrying an inter-subunit disulfide bond (SOS virus) showed that the neutralization-susceptible timeframe after attachment was 60 to 120 min. These results indicate that the scFvs efficiently access the V3 loop and subsequently neutralize HIV-1, even after virus attachment to the target cells. Based on its broad and potent neutralizing activity, further development of anti-V3 scFv for therapeutic and preventive strategies is warranted.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902223     DOI: 10.7883/yoken.JJID.2015.667

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

1.  Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV.

Authors:  Sarah B Lloyd; Keith P Niven; Ben R Kiefel; David C Montefiori; Arnold Reynaldi; Miles P Davenport; Stephen J Kent; Wendy R Winnall
Journal:  Hum Vaccin Immunother       Date:  2017-09-26       Impact factor: 3.452

2.  Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.

Authors:  Kazuki Tanaka; Takeo Kuwata; Muntasir Alam; Gilad Kaplan; Shokichi Takahama; Kristel Paola Ramirez Valdez; Anna Roitburd-Berman; Jonathan M Gershoni; Shuzo Matsushita
Journal:  Retrovirology       Date:  2017-09-22       Impact factor: 4.602

3.  Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode

Authors:  Saba Karam; Mozhgan Raigani; Sahar Hassani Afshar; Yeganeh Talebkhan; Elham Bayat; Samira Komijani; Leila Nematollahi; Farzaneh Barkhordari; Mehdi Shafiee Ardestani; Fatemeh Davami
Journal:  Iran Biomed J       Date:  2021-11-01

4.  Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors.

Authors:  Mohammad Mamun Alam; Takeo Kuwata; Kazuki Tanaka; Muntasir Alam; Shokichi Takahama; Kazuya Shimura; Masao Matsuoka; Natsuki Fukuda; Hiroshi Morioka; Hirokazu Tamamura; Shuzo Matsushita
Journal:  Biochem Biophys Rep       Date:  2019-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.